Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

9.75
Delayed Data
As of 3:52pm ET
 +0.09 / +0.93%
Today’s Change
1.86
Today|||52-Week Range
19.68
+84.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization144.7K366.9K740.7K752.0K
 
 
 
 
 
 
Operating ExpensesGross Income-144.7K-366.9K-740.7K-752.0K
 
 
 
 
 
General Expenses8.5M12.4M18.3M17.1M
 
 
 
 
 
Research And Development4.1M6.4M10.5M10.3M
 
 
 
 
 
Total Operating Expenses8.7M12.8M19.0M17.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.7M-12.8M-19.0M-17.8M
 
 
 
 
 
Extraordinary Credit0.0017.5M----
 
 
Extraordinary Charge-26.1M0.00-19.6M-376.0K
 
 
 
 
Interest Expense On Debt16.7K71.7K129.9K136.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.7M4.7M-38.8M-18.3M
 
 
 
 
 
Net Income-34.7M4.7M-38.8M-18.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.0M15.8M18.5M22.1M
 
 
 
 
 
Shares To Calculate EPS Diluted13.0M18.0M18.5M22.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.68$0.24-$2.08-$0.84
 
 
 
 
 
EPS Diluted-$2.68$0.24-$2.08-$0.84